Description of key strategic decisions facing the scientific founder and CEO of promising early stage bio-pharmaceutical company. In the event that the company has offered to create an alliance with a pharmaceutical company? Whether it should create a nutraceuticals business in parallel to its efforts to develop an anti-aging treatment? And if he is licensed second candidate for drug development? "Hide
by Toby Stuart, James Webber Source: Harvard Business School 10 pages. Publication Date: 04 Oct 2012. Prod. #: 813029-PDF-ENG
Related Case Solutions & Analyses:
Introduction to Business Government and the International Economy (BGIE) Course Overview
Meetup
Organizational Alignment Performance and Change in Professional Service Firms
Warren E. Buffett 2008
Bobbie DAlessandro and the Redesign of the Cambridge Rindge and Latin School
Flagstar Cos. Inc.
Wells Fargo Online Financial Services (A)
Spotify: Face the music
Walmart Inc. Takes on Amazon.com
MMA 801 Introduction to Management
